International audienceDownstream processing (DSP) of large bionanoparticles is still a challenge. The present study aims to systematically compare some of the most commonly used DSP strategies for capture and purification of enveloped viruses and virus-like particles (eVLPs) by using the same staring material and analytical tools. As a model, Human Immunodeficiency Virus-1 (HIV-1) gag VLPs produced in CHO cells were used. Four different DSP strategies were tested. An anion-exchange monolith and a membrane adsorber, for direct capture and purification of eVLPs, and a polymer-grafted anion-exchange resin and a heparin-affinity resin for eVLP purification after a first flow-through step to remove small impurities. All tested strategies were su...
Limited binding capacity and low recovery of large size multi-subunits virus-like particles (VLPs) i...
AbstractA two step flow-through chromatography process is proposed as an universal approach to purif...
Background: Purification of virus particles for vaccines and viral vectors for gene therapy is a maj...
International audienceDownstream processing (DSP) of large bionanoparticles is still a challenge. Th...
International audiencePolymer-grafted chromatography media, especially ion exchangers, are high perf...
Usually, the downstream processing of viruses and virus-like particles (VLP) does not include conven...
AbstractEnveloped virus-like particles (VLPs) are increasingly used as vaccines and immunotherapeuti...
Biotechnological and pharmaceutical industries have the development of modern vaccines and novel dru...
HIV-1-based virus-like particles (VLPs) have high potential as scaffold for the development of chime...
In recent years, interest in macroporous matrices like membrane adsorber and monoliths for the purif...
Hepatitis B virus-like particles expressed in Escherichia coli were purified using anion exchange ad...
Human influenza vaccines are traditionally produced in embryonated chicken eggs. However, due to sev...
Virus-like particles (VLPs) have become widely used as vaccine candidates because of their versatili...
A virus-like particle (VLP) is a biological nanoparticle. It consists of the protective protein shel...
Advancement in genetic engineering has allowed the expression of virus-like particle (VLP) in variou...
Limited binding capacity and low recovery of large size multi-subunits virus-like particles (VLPs) i...
AbstractA two step flow-through chromatography process is proposed as an universal approach to purif...
Background: Purification of virus particles for vaccines and viral vectors for gene therapy is a maj...
International audienceDownstream processing (DSP) of large bionanoparticles is still a challenge. Th...
International audiencePolymer-grafted chromatography media, especially ion exchangers, are high perf...
Usually, the downstream processing of viruses and virus-like particles (VLP) does not include conven...
AbstractEnveloped virus-like particles (VLPs) are increasingly used as vaccines and immunotherapeuti...
Biotechnological and pharmaceutical industries have the development of modern vaccines and novel dru...
HIV-1-based virus-like particles (VLPs) have high potential as scaffold for the development of chime...
In recent years, interest in macroporous matrices like membrane adsorber and monoliths for the purif...
Hepatitis B virus-like particles expressed in Escherichia coli were purified using anion exchange ad...
Human influenza vaccines are traditionally produced in embryonated chicken eggs. However, due to sev...
Virus-like particles (VLPs) have become widely used as vaccine candidates because of their versatili...
A virus-like particle (VLP) is a biological nanoparticle. It consists of the protective protein shel...
Advancement in genetic engineering has allowed the expression of virus-like particle (VLP) in variou...
Limited binding capacity and low recovery of large size multi-subunits virus-like particles (VLPs) i...
AbstractA two step flow-through chromatography process is proposed as an universal approach to purif...
Background: Purification of virus particles for vaccines and viral vectors for gene therapy is a maj...